Akero Therapeutics stock strengthened as Morgan Stanley reiterates Overweight rating
Akero Therapeutics Stock Rises as Morgan Stanley Reaffirms Overweight Rating Akero Therapeutics stock saw a boost following Morgan Stanley’s reiterated “Overweight” rating. This positive assessment underscores the investment bank’s continued...